Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study,...

Published on 25 Nov 2024 on Benzinga · via Yahoo Finance

Cassava Sciences Inc. (NASDAQ:SAVA) stock plunged Monday after the company released topline data...

Read the rest of the article

Start tracking your investments with Statfolio

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a...

Benzinga 30 Nov 2024

Aβ is a protein that is said to be the primary cause of the cognitive decline associated with...

Zacks · via Yahoo Finance 26 Nov 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 26 Nov 2024

Cassava Sciences (SAVA) has become technically an oversold stock now, which implies exhaustion of...

Zacks · via Yahoo Finance 26 Nov 2024

United States shares higher at close of trade; Dow Jones Industrial Average up 0.99%

Investing.com 25 Nov 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.99%

Investing.com 25 Nov 2024

Cassava Sciences Inc. (NASDAQ:SAVA) stock plunged Monday after the company released topline data...

Benzinga · via Yahoo Finance 25 Nov 2024

Despite the recent downturn, Cassava Sciences has experienced a notable 1-year change, with its...

Investing.com 25 Nov 2024

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks · via Yahoo Finance 15 Nov 2024

We recently published an article titled, Jim Cramer’s Latest Lightning Round: 12 Stocks to Watch....

Insider Monkey · via Yahoo Finance 18 Oct 2024